TMCnet News
Research and Markets: 2015 Strategies in the Global Tumor Marker Testing MarketResearch and Markets (http://www.researchandmarkets.com/research/8xmdsq/2015_strategies) has announced the addition of the "2015 Strategies in the Global Tumor Marker Testing Market: US, Europe, Japan" report to their offering. Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years. Examines trends in the U.S., Europe and Japan. Reviews current and emerging tumor markers. Analyzes applications of emerging diagnostic technologies. Forecasts sales of major tumor markers by country and market segment. Profiles leading market players and potential entrants.
- Abbott - Beckman Coulter/Danaher (News - Alert) - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - Enzo Biochem - Guided Therapeutics - Hologic/Gen-Probe - Kreatech - Kyowa Medex - Mackay (News - Alert) Life Sciences - Myriad Genetics - PreMD - Qiagen/Ipsogen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Sequenom - Siemens (News - Alert) Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Thermo Fisher/Life Technologies - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/8xmdsq/2015_strategies
View source version on businesswire.com: http://www.businesswire.com/news/home/20150529005448/en/ |